Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.007 | 0.6669 | 0.6669 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0029 | 0.0755 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0094 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0094 | 1 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.0023 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0 | 0.5 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.0023 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0029 | 0.0755 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 0 | Growth inhibition of human NCI-H460 cells by MTT assay | ChEMBL. | 17049252 |
IC50 (functional) | 0 | Growth inhibition of human HCT116 cells by MTT assay | ChEMBL. | 17049252 |
IC50 (functional) | 0 | Growth inhibition of human A431 cells by MTT assay | ChEMBL. | 17049252 |
IC50 (functional) | 0 | Growth inhibition of human CCRF-HSB-2 cells by MTT assay | ChEMBL. | 17049252 |
IC50 (functional) | 0 | Growth inhibition of human KB cells by MTT assay | ChEMBL. | 17049252 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.